Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Treatment responses of BRAF mutant melanoma to BRAF inhibitors are often limited by the development of resistance. This case report describes the use of multiplatform molecular profiling in sequential surgical samples of a treatment-resistant tumour site subjected to ongoing treatment with dabrafeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Gabriel, Arkenau, Hendrik-Tobias, Chin, Melvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086757/
https://www.ncbi.nlm.nih.gov/pubmed/24858661
http://dx.doi.org/10.1097/CMR.0000000000000085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086757/
https://www.ncbi.nlm.nih.gov/pubmed/24858661
http://dx.doi.org/10.1097/CMR.0000000000000085

Ejemplares similares